CoChat

Making prescriptions “talk” to stroke and heart attack survivors to improve adherence: Results of a randomized clinical trial (The Talking Rx Study)

Open access
Kamal, Ayeesha Kamran, Khalid, Wardah, Muqeet, Abdul, Jamil, Anum, Farhat, Kashfa, Gillani, Sehar Rahim Ali, Zulfiqar, Maryam, Saif, Mehreen, Muhammad, Aliya Amin, Zaidi, Fabiha, Mustafa, Mohammad, Gowani, Ambreen, Sharif, Shahrukh, Bokhari, Syedah Saira, Tai, Javed, Rahman, Nasir, Sultan, Fateh Ali Tipoo, Sayani, Saleem, Virani, Salim S. · 2018 · PLOS ONE
Cited by 43

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Abstract

BACKGROUND: We developed and tested the effectiveness of a tailored health information technology driven intervention: "Talking Prescriptions" (Talking Rx) to improve medication adherence in a resource challenged environment. METHODS: We conducted a parallel, randomized, controlled, assessor-blinded trial at the Aga Khan University (AKU), Karachi, Pakistan. Adults with diagnosis of cerebrovascular accident (CVA) or coronary artery disease (CAD) diagnosed least one month before enrollment, on anti-platelets and statins, with access to a mobile phone were enrolled. The intervention group received a) Daily Interactive Voice Response (IVR) call services regarding specific statin and antiplatelet b) Daily tailored medication reminders for statin and antiplatelet and c) Weekly lifestyle modification messages for a period of 3 months. We assessed Medication adherence to statin and antiplatelets by a validated version of the 8-item Morisky Medication Adherence scale 8 (MMAS-8) at 3 months by a blinded assessment officer. Analysis was conducted by intention-to-treat principle (ITT). RESULTS: Between April 2015 and December 2015, 197 participants (99 in intervention and 98 in the usual care group) enrolled in the Talking Rx Study. The dropout rate was 9.6%. Baseline group characteristics were similar. At baseline, the mean MMAS-8 was 6.68 (SD = 1.28) in the intervention group and 6.77 (SD = 1.36) in usual care group. At end of follow-up, the mean MMAS-8 increased to 7.41(0.78) in the intervention group compared with 7.38 (0.99) in usual care group with mean difference of 0.03 (S.D 0.13) (95% C.I [-0.23, 0.29]), which was not statistically significant. (P-Value = 0.40) CVA patients showed a relatively greater magnitude of adherence via the MMAS-8 at the end of follow up where the mean MMAS-8 increased to 7.29 (S.D 0.82) in the intervention group as compared to 7.07(S.D 1.24) in usual care group with mean difference of 0.22 (SD = 0.22) 95% C.I (-0.20, 0.65) with (P-value = 0.15). Around 84% of those on intervention arm used the service, calling at least 3 times and listening to their prescriptions for an average of 8 minutes. No user was excluded due to technologic reasons. CONCLUSION: The use of a phone based medication adherence program was feasible in LMIC settings with high volume clinics and low patient literacy. In this early study, with limited follow up, the program did not achieve any statistically significant differences in adherence behavior as self-reported by the MMAS-8 Scale. TRIAL REGISTRATION: Clinical Trials.gov NCT02354040.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0197671

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Research works printed but not linked: 12

  1. CJL Murray, 1997, Mortality by cause for eight regions of the world: Global Burden of Disease Study, The Lancet, 349, 1269, 10.1016/S0140-6736(96)07493-4 · DOI · Paper page
  2. AK Kamal, 2009, The burden of stroke and transient ischemic attack in Pakistan: a community-based prevalence study, BMC neurology, 9, 1, 10.1186/1471-2377-9-58 · DOI
  3. TH Jafar, 2005, Heart disease epidemic in Pakistan: women and men at equal risk, American heart journal, 150, 221, 10.1016/j.ahj.2004.09.025 · DOI
  4. S De Geest, 2003, Adherence to long-term therapies: evidence for action, European Journal of Cardiovascular Nursing, 2, 323, 10.1016/S1474-5151(03)00091-4 · DOI · Paper page
  5. SK Hashmi, 2007, Factors associated with adherence to anti-hypertensive treatment in Pakistan, PLoS One, 2, e280, 10.1371/journal.pone.0000280 · DOI · Paper page
  6. H Arif, 2007, Drug compliance after stroke and myocardial infarction: A comparative study, Neurology India, 55, 130, 10.4103/0028-3886.32783 · DOI
  7. TH Jafar, 2013, Non-communicable diseases and injuries in Pakistan: strategic priorities, The Lancet, 381, 2281, 10.1016/S0140-6736(13)60646-7 · DOI
  8. R Horton, 2013, Pakistan: health is an opportunity to be seized, The Lancet, 381, 2137, 10.1016/S0140-6736(13)60946-0 · DOI
  9. H Zhou, Impact of Text Message Reminders on Caregivers’ Adherence to a Home Fortification Program Against Child Anemia in Rural Western China: A Cluster-Randomized Controlled Trial, American Journal of Public Health, e1
  10. AK Kamal, 2016, Using a tailored health information technology-driven intervention to improve health literacy and medication adherence in a Pakistani population with vascular disease (Talking Rx)–study protocol for a randomized controlled trial, Trials, 17, 1, 10.1186/s13063-016-1244-1 · DOI
  11. F Saleem, 2012, Translation and validation study of Morisky Medication Adherence Scale (MMAS): the Urdu version for facilitating person-centered healthcare in Pakistan, International Journal of Person Centered Medicine, 2, 384
  12. S Zaidi, 2013, Access to essential medicines in Pakistan: policy and health systems research concerns, PloS one, 8, e63515, 10.1371/journal.pone.0063515 · DOI

Cited by

See all 43

Metadata

Authors
Kamal, A. K., Khalid, W., Muqeet, A., Jamil, A., Farhat, K., Gillani, S. R. A., Zulfiqar, M., Saif, M., Muhammad, A. A., Zaidi, F., Mustafa, M., Gowani, A., Sharif, S., Bokhari, S. S., Tai, J., Rahman, N., Sultan, F. A. T., Sayani, S., & Virani, S. S.
Venue
PLOS ONE
Published
2018-12-20
Volume
13
Issue
12
Pages
e0197671
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2906223012
Cited by
43
References
15
FWCI
4.52
Type
journal article
Language
en
Open access
gold
Funders
Baylor College of Medicine (US), Center for Globalization

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.